Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Apoplexy
100%
Transient Ischemic Attack
84%
Cerebral Hemorrhage
66%
Brain Ischemia
59%
Vertebral Artery Dissection
58%
Antithrombotic
46%
Anticoagulation
42%
Hemodynamic
41%
Acetylsalicylic Acid
39%
Symptom
35%
Infarction
33%
Hematoma
31%
Diffusion MRI
29%
Limb
27%
Oxygen 15
27%
Bypass Surgery
26%
Magnetic Resonance Imaging
23%
Cohort Analysis
23%
Prospective Cohort Study
23%
Tenecteplase
23%
Central Retinal Artery Occlusion
23%
Odds Ratio
20%
Acetazolamide
20%
Randomized Controlled Trial
19%
Vitamin K Antagonist
19%
Positron Emission Tomography
18%
Best Corrected Visual Acuity
17%
Deterioration
17%
Positron Emission Tomography
16%
Brain Blood Flow
16%
Atherosclerosis
15%
Gray Matter
14%
Subgroup Analysis
14%
Prevalence
14%
Computed Tomography Angiography
13%
Bleeding
13%
Artery
11%
Ischemia
11%
Perfusion Weighted Imaging
11%
Revascularization
11%
Elderly Patient
11%
Sex Difference
11%
Paroxysmal Atrial Fibrillation
11%
Tissue Plasminogen Activator
11%
Susceptibility Weighted Imaging
11%
Moyamoya Disease
11%
Arterial Spin Labeling
11%
Thrombus
11%
Vertebral Artery
11%
Clinical Significance
11%
Keyphrases
Intracerebral Hemorrhage
60%
Transient Ischemic Attack
52%
Oral Anticoagulants
46%
Aspirin
35%
Cervical Artery Dissection (CeAD)
34%
Anticoagulation
34%
Modified Rankin Scale
25%
Spontaneous Intracerebral Hemorrhage
25%
Hematoma Expansion
25%
Acute Ischemic Stroke
24%
Vitamin K Antagonists
23%
Sex Differences
23%
Limb-shaking Transient Ischemic Attack
23%
15O-H2O
23%
Prospective Cohort Study
23%
Moyamoya Disease
23%
Randomized Trial
23%
Tenecteplase
23%
Central Retinal Artery Occlusion
23%
Symptom Onset
23%
Ischemic Stroke
22%
Fluid-attenuated Inversion Recovery (FLAIR)
21%
Diffusion-weighted Imaging
19%
National Institutes of Health Stroke Scale (NIHSS)
19%
Hemodynamic Insufficiency
19%
Risk Factors
18%
Infarction
18%
Randomized Controlled Trial
17%
Extracranial-intracranial Bypass
17%
Best-corrected Visual Acuity
17%
Neurological Deterioration
17%
Acute Stroke
16%
Cryptogenic Stroke
16%
Denmark
15%
Cerebral Hemodynamics
15%
Capital Region
15%
Bypass Patency
14%
Gray Matter Volume
14%
Confidence Interval
14%
Perfusion
14%
Signal Intensity
13%
Comorbidity
13%
EC-IC Bypass
13%
Stroke Ischemic
13%
Stroke Risk
12%
Clinical Significance
12%
Phase II Trial
12%
Ultrasound
12%
Hemodynamic Failure
11%
Subgroup Analysis
11%